Endurance Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $25.8M | Sell |
49,380
-137
| -0.3% | -$73.9K | 3.52% | 4 |
|
|
2023
Q1 | $28.5M | Sell |
49,517
-138
| -0.3% | -$77.8K | 4.04% | 4 |
|
|
2022
Q4 | $27.3M | Buy |
49,655
+746
| +2% | +$395K | 4.12% | 3 |
|
|
2022
Q3 | $24.8M | Sell |
48,909
-266
| -0.5% | -$149K | 4.1% | 4 |
|
|
2022
Q2 | $26.7M | Buy |
49,175
+17
| +0% | +$9.36K | 4.06% | 4 |
|
|
2022
Q1 | $29M | Sell |
49,158
-4,999
| -9% | -$2.87M | 3.76% | 4 |
|
|
2021
Q4 | $36.1M | Sell |
54,157
-3,548
| -6% | -$2.22M | 3.89% | 4 |
|
|
2021
Q3 | $33M | Sell |
57,705
-1,155
| -2% | -$634K | 3.67% | 4 |
|
|
2021
Q2 | $29.7M | Sell |
58,860
-331
| -0.6% | -$156K | 3.29% | 5 |
|
|
2021
Q1 | $27M | Sell |
59,191
-252
| -0.4% | -$120K | 3.18% | 5 |
|
|
2020
Q4 | $27.7M | Buy |
59,443
+402
| +0.7% | +$188K | 3.5% | 5 |
|
|
2020
Q3 | $26.1M | Sell |
59,041
-1,268
| -2% | -$524K | 3.84% | 5 |
|
|
2020
Q2 | $21.9M | Sell |
60,309
-678
| -1% | -$227K | 3.58% | 5 |
|
|
2020
Q1 | $17.3M | Sell |
60,987
-526
| -0.9% | -$166K | 3.32% | 5 |
|
|
2019
Q4 | $20M | Sell |
61,513
-290
| -0.5% | -$87.9K | 3.06% | 5 |
|
|
2019
Q3 | $18M | Sell |
61,803
-234
| -0.4% | -$67K | 2.99% | 6 |
|
|
2019
Q2 | $18.2M | Sell |
62,037
-804
| -1% | -$221K | 2.87% | 5 |
|
|
2019
Q1 | $17.2M | Sell |
62,841
-305
| -0.5% | -$75.9K | 2.82% | 6 |
|
|
2018
Q4 | $14.1M | Buy |
63,146
+229
| +0.4% | +$53.7K | 2.63% | 6 |
|
|
2018
Q3 | $15.4M | Sell |
62,917
-1,024
| -2% | -$236K | 2.42% | 8 |
|
|
2018
Q2 | $13.2M | Sell |
63,941
-385
| -0.6% | -$81.7K | 2.18% | 12 |
|
|
2018
Q1 | $13.3M | Sell |
64,326
-1,088
| -2% | -$228K | 2.23% | 10 |
|
|
2017
Q4 | $12.4M | Sell |
65,414
-350
| -0.5% | -$67K | 2% | 12 |
|
|
2017
Q3 | $12.4M | Sell |
65,764
-477
| -0.7% | -$86.4K | 2.06% | 10 |
|
|
2017
Q2 | $11.6M | Sell |
66,241
-89
| -0.1% | -$14.9K | 1.95% | 12 |
|
|
2017
Q1 | $10.2M | Buy |
66,330
+1,169
| +2% | +$179K | 1.76% | 15 |
|
|
2016
Q4 | $9.19M | Buy |
65,161
+980
| +2% | +$144K | 1.64% | 19 |
|
|
2016
Q3 | $10.2M | Sell |
64,181
-813
| -1% | -$125K | 1.83% | 9 |
|
|
2016
Q2 | $9.6M | Buy |
64,994
+1,035
| +2% | +$153K | 1.8% | 12 |
|
|
2016
Q1 | $9.06K | Buy |
63,959
+4,053
| +7% | +$543K | 1.27% | 15 |
|
|
2015
Q4 | $8.5M | Sell |
59,906
-1,309
| -2% | -$175K | 1.62% | 18 |
|
|
2015
Q3 | $7.71M | Sell |
61,215
-269
| -0.4% | -$35K | 1.35% | 19 |
|
|
2015
Q2 | $7.98M | Sell |
61,484
-1,461
| -2% | -$190K | 1.34% | 21 |
|
|
2015
Q1 | $8.46M | Sell |
62,945
-467
| -0.7% | -$60.2K | 1.48% | 20 |
|
|
2014
Q4 | $7.94M | Sell |
63,412
-940
| -1% | -$114K | 1.42% | 19 |
|
|
2014
Q3 | $7.83M | Buy |
64,352
+159
| +0.2% | +$19.3K | 1.46% | 20 |
|
|
2014
Q2 | $7.57M | Sell |
64,193
-975
| -1% | -$115K | 1.26% | 22 |
|
|
2014
Q1 | $7.83M | Sell |
65,168
-310
| -0.5% | -$36.9K | 1.52% | 16 |
|
|
2013
Q4 | $7.29M | Sell |
65,478
-469
| -0.7% | -$46.6K | 1.44% | 19 |
|
|
2013
Q3 | $6.08M | Sell |
65,947
-275
| -0.4% | -$24.9K | 1.29% | 25 |
|
|
2013
Q2 | $5.6M | Buy |
+66,222
| New | +$5.51M | 1.25% | 24 |
|
Other funds holding TMO
Endurance Wealth Management's TMO Position: Q2 2023 in Review
Endurance Wealth Management reduced its Thermo Fisher Scientific (TMO) stake by 0.28% in Q2 2023, selling an estimated $73.9K and leaving 49,380 shares worth $25.8M. The position accounts for 3.52% of the portfolio, ranked #4.
Endurance Wealth Management first reported a position in TMO in Q2 2013 and has held it in 41 quarters since. The position peaked at $36.1M in Q4 2021. 2,387 funds tracked by Wall St. Rank hold TMO as of Q2 2023.
- Endurance Wealth Management held 49,380 shares of Thermo Fisher Scientific worth $25.8M as of Q2 2023.
- Endurance Wealth Management sold 137 Thermo Fisher Scientific shares in Q2 2023, an estimated $73.9K.
- Thermo Fisher Scientific made up 3.52% of Endurance Wealth Management's portfolio in Q2 2023, its #4 holding.
- Endurance Wealth Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 41 quarters since.
- Endurance Wealth Management's Thermo Fisher Scientific position peaked at $36.1M in Q4 2021.
- 2,387 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2023.
Based on Endurance Wealth Management's 13F filing for Q2 2023, filed 9 Aug 2023.